Meaning-Centered Psychotherapy in Advanced Cancer

Sponsor

National Center for Complementary and Integrative Health (NCCIH) (NIH)

Overall Status

Completed

CT.gov ID

NCT00067288

Collaborator

(none)

118

Enrollment

Location

Duration (Months)

2.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.

Condition or Disease	Intervention/Treatment	Phase
Lymphoma, Non-Hodgkin Neoplasms	Behavioral: Meaning-Centered Group Psychotherapy Behavioral: Standard Supportive Group Psychotherapy	Phase 2

Detailed Description

As per Brief Summary

Study Design

Study Type:

Interventional

Allocation:

Randomized

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Educational/Counseling/Training

Official Title:

Meaning-Centered Psychotherapy in Advanced Cancer

Study Start Date :

May 1, 2002

Study Completion Date :

Mar 1, 2006

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

21 Years to 0 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

21 years of age or older;
English speaking;
Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma;
Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City;

Exclusion Criteria:

Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention;
Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent;
Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Memorial Sloan-Kettering Institute for Cancer Research	New York	New York	United States	10021

Sponsors and Collaborators

National Center for Complementary and Integrative Health (NCCIH)

Investigators

Principal Investigator: William Breitbart, MD, Memorial Sloan Kettering Cancer Center
: Christopher Gibson, PhD, Project Coordinator Memorial Sloan-Kettering Cancer Center